Heart Failure in South America

Abstract

Continued assessment of temporal trends in mortality and epidemiology of specific heart failure in South America is needed to provide a scientific basis for rational allocation of the limited health care resources, and strategies to reduce risk and predict the future burden of heart failure. The epidemiology of heart failure in South America was reviewed. Heart failure is the main cause of hospitalization based on available data from approximately 50% of the South American population. The main etiologies of heart failure are ischemic, idiopathic dilated cardiomyopathy, valvular, hypertensive and chagasic etiologies. In endemic areas, Chagas heart disease may be responsible by 41% of the HF cases. Also, heart failure presents high mortality especially in patients with Chagas etiology. Heart failure and etiologies associated with heart failure may be responsible for 6.3% of causes of deaths. Rheumatic fever is the leading cause of valvular heart disease. However, a tendency to reduction of HF mortality due to Chagas heart disease from 1985 to 2006, and reduction in mortality due to HF from 1999 to 2005 were observed in selected states in Brazil. The findings have important public health implications because the allocation of health care resources, and strategies to reduce risk of heart failure should also consider the control of neglected Chagas disease and rheumatic fever in South American countries.

The changing face of cardiovascular disease 2000–2012: An analysis of the world health organisation global health estimates data

“…46 There are 6-7 million cases of Chagas disease, with an estimated 25-41% of patients developing HF. 46,47 The challenge in estimating HF's specific global burden is partly due to lack of uniformity in making the diagnosis. ICD-10 does not clearly define HF as a separate diagnosis and as such HF is not examined in the GBD study.…”

Knowledge, barriers and attitudes toward dietary sodium in patients with decompensated heart failure

“…[1] In South America, HF is the main cause of hospitalization based on available data from approximately 50% of the population. [2] Decompensated HF requires immediate institution of therapy and subsequent hospitalization. At hospital admission, these patients predominantly exhibit congestive manifestations, [3,4] with hypervolemia accounting for 80.7% of hospitalizations due to decompensated HF.…”

Controlling acute rheumatic fever and rheumatic heart disease in developing countries

“…Despite the advantages of disease prevention, some countries have no prevention or screening programme in place (e.g. Brazil) [47]. In Nepal, however, a national programme has been integrated into primary healthcare since 2007 and in 2013 a pilot primary prevention project was initiated at 42 primary healthcare centres, using a 'treat all' approach for GAS pharyngitis [48].…”